FSD Pharma (CSE:HUGE) CEO Thomas Fairfull, CCO Michael Ash and Director Anthony Durkacz were featured in a video profile produced by BTV. In the video, the narrator introduces FSD Pharma as being a record breaker on the CSE, having already surpassed more than a billion shares on the national stock exchange.

The FSD Pharma executives discussed the ongoing retrofit initiatives for their former Kraft manufacturing facility, located nearby Cobourg, Ontario, in partnership with Auxly Cannabis Group (TSXV:XLY). The facility will be developed as a cultivation and distribution operation, targeting the medical cannabis market.


“My vision is to make this the largest hydroponic medical marijuana facility in the world,” Fairfull is quoted as saying. “We will bring a lot of help and relief to a lot of people.”

Ash also discussed the opportunities still emerging in the medical cannabis market, including the recent FDA approval of the first cannabinoid-based prescription product. He also believes that the cannabinoid industry will help meet the same needs targeted by the vitamin and health and wellness markets.

To see the video and the subsequent company description, click here.

Click here to connect with FSD Pharma (CSE:HUGE) for an Investor Presentation.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less